Sanctuary Advisors LLC bought a new stake in shares of Cabot Corporation (NYSE:CBT – Free Report) in the 2nd quarter, Holdings Channel reports. The fund bought 10,242 shares of the specialty chemicals company’s stock, valued at approximately $930,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Cabot in the second quarter worth about $33,000. Evolve Private Wealth LLC purchased a new position in Cabot in the second quarter valued at about $264,000. William Blair Investment Management LLC purchased a new stake in Cabot during the 2nd quarter worth approximately $16,809,000. Allworth Financial LP purchased a new stake in Cabot during the 2nd quarter worth approximately $145,000. Finally, Advisors Capital Management LLC acquired a new position in shares of Cabot in the 2nd quarter valued at approximately $267,000. 93.18% of the stock is owned by hedge funds and other institutional investors.
Cabot Price Performance
Shares of NYSE CBT opened at $84.58 on Friday. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $4.37 billion, a price-to-earnings ratio of 23.83, a price-to-earnings-growth ratio of 11.11 and a beta of 0.84. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The business has a 50 day simple moving average of $87.77 and a 200-day simple moving average of $81.18.
Cabot Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. Cabot’s payout ratio is 53.24%.
Insider Buying and Selling at Cabot
In related news, CEO Sean D. Keohane sold 2,779 shares of the business’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $85.50, for a total transaction of $237,604.50. Following the completion of the sale, the chief executive officer owned 288,873 shares of the company’s stock, valued at $24,698,641.50. This represents a 0.95% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.08% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several research firms have recently commented on CBT. JPMorgan Chase & Co. increased their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Finally, UBS Group dropped their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $89.00.
View Our Latest Stock Report on CBT
Cabot Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
- Five stocks we like better than Cabot
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
